MEF2D anticorps (pSer444) (Cy5)

N° du produit ABIN710520

Détail du produit anti-MEF2D anticorps (Cy5)

Antigène: MEF2D (Myocyte Enhancer Factor 2D (MEF2D))

Épitope: pSer444

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MEF2D est conjugé à/à la Cy5

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Flow Cytometry (FACS)

Réactivité croisée: Humain, Souris, Rat

Homologie: Cow,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic phosphopeptide derived from human MEF2D around the phosphorylation site of Ser444

Isotype: IgG

Information d'application

Indications d'application: FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur MEF2D

Antigène: MEF2D (Myocyte Enhancer Factor 2D (MEF2D))

Autre désignation: MEF2D (MEF2D Produits)

Synonymes: anticorps sl1, anticorps sl-1, anticorps XMEF2D, anticorps MGC145245, anticorps C80750, anticorps myocyte enhancer factor 2D, anticorps MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D), anticorps mef2d, anticorps MEF2D, anticorps Mef2d

Sujet:

Synonyms: MEF2Dphospho S444, DKFZp686I1536, MADS box transcription factor 2 polypeptide D, Mef2d, MEF2D_HUMAN, myocyte enhancer factor 2D, Myocyte specic enhancer factor 2, polypeptide D, Myocyte specic enhancer factor 2D, myocyte-specic enhancer factor 2D.

Background: MEF2D is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants.

ID gène: 4209